⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZYME News
Zymeworks Inc.
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
globenewswire.com
ZYME
A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs
prnewswire.com
GTBP
XNCR
CTMX
ZYME
NRIX
Form 8-K
sec.gov
ZYME
Zymeworks to Acquire Theravance Biopharma, Inc.
globenewswire.com
ZYME
TBPH
Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery
prnewswire.com
ZYME
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
globenewswire.com
ZYME
Form 8-K
sec.gov
ZYME
Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock
globenewswire.com
ZYME
Zymeworks Announces Participation in Upcoming Investor Conferences
globenewswire.com
ZYME
Form 8-K
sec.gov
ZYME